CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysis
Autor: | Agostinetto, E., Vian, L., Caparica, R., Bruzzone, M., Ceppi, M., Lambertini, M., Pondé, N., de Azambuja, E. |
---|---|
Zdroj: | In ESMO Open April 2021 6(2) |
Databáze: | ScienceDirect |
Externí odkaz: |